Investigation on the Transport Characteristics of P-Glycoprotein and Related Transporters Contributing Low Oral Bioavailability of Various Drugs.
Investigation on the Transport Characteristics of P-Glycoprotein and Related Transporters Contributing Low Oral Bioavailability of Various Drugs.
批准号:
10672091
负责人:
SAITOH Hiroshi
金额:
$1.73万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
使用大鼠小睾丸激素、可可-2细胞和LLC-PK D21和D2细胞,我们对P-糖蛋白质和相关肠道效应系统的运输特性进行了研究,从而为各种药物的低口腔生物可用性提供了研究。在这一研究中发现的发现是:(1)吸血霉素和阿贝卡辛展示了高度机密的渗透行为,跨越大鼠小意图。这个过程是由多能源依赖的效应系统介导的。P-糖蛋白质是在吸血鬼霉素效应中部分参与的,在作为一个专门的运输机的情况下,它没有在Caco-2细胞膜上表达,有效地运输其他氨基葡萄糖化合物,如良好的arbekacin。(2)甲硫二酮吸收在大鼠intestine中受到P-葡萄糖蛋白质的显著影响,特别是在利比里亚地区。Prednisolone和hydrocortisone是weaker substrates of P-glycoprotein的甲基Prednisolone,建议类固醇激素侧链结构中的轻微差异明显地改变了它们的亲和力 ... More P-glycoprotein。对P-葡萄糖蛋白质在性荷尔蒙等催乳素和睾丸激素的吸收中没有限制。(3)Vinblastine的大鼠体内吸收,一个众所周知的P-糖蛋白质基质,在大鼠二丁二烯和锂中的快速反应比预期的要快。However,从Jejunum吸收葡萄糖几乎是有害的,建议用区域依赖性的术语限制P-糖蛋白质吸收葡萄糖。这样的观察是无法在使用Caco-2细胞的研究中发现的。(4)当对秘密传输、β-乳藻抗微生物与大鼠结肠直肠癌的渗透参数进行正确处理时,它们与人类的口腔生物利用率良好相关。作为一种新的依据,巴坎皮林增加了ampicillin吸收的机理,它被描述为羟基产品,是哪一种形成在表皮中,抑制了β-乳杆菌抗生素的效应系统。(5) [JED 13 JED 1H] Vinblastine, absorbed from duodenum and ileum, is secreted into jejunal lumen much greater when unlabeled Vinblastine is loaded in jejunal loop than when无药物缓冲液被引入。Unlabeled vinblastine also enhances the basolateral-to-apical transport of [イイD13イエD1H] vinblastine mediated by P-glycoprotein across Caco-2 cell monolayers。However,其他P-糖蛋白底物,如多巴胺、文克里斯汀和甲基predni-solone失败,以表现出这样的效果。一个可能的解释是,在表观细胞的物理表面上,表面上相同的物质的存在是刺激P-糖蛋白质介导的传输的关键。Less(低)
英文摘要
Using rat small intestine, Caco-2 cells, and LLC-PKィイD21ィエD2 cells, we investigated transport characteristics of P-glycoprotein and related intestinal efflux system contributing the low oral bioavailability of various drugs. The findings obtained in this study were as follows:(1) Vancomycin and arbekacin exhibit highly secretory-oriented permeation manner across rat small intestine. The process is mediated by plural energy-dependent efflux systems. P-Glycoprotein is in part involved in vancomycin efflux, whereas a specialized transporter, which is not expressed on Caco-2 cell membrane, efficiently transports other aminoglycosides as well as arbekacin.(2) Methyiprednisolone absorption is markedly affected by P-glycoprotein in the rat intestine, especially in the ileal region. Prednisolone and hydrocortisone are weaker substrates of P-glycoprotein than methylprednisolone, suggesting that slight differences in side chain structure of steroid hormones are significantly alter their affinity … More to P-glycoprotein. There is no restriction due to P-glycoprotein in the absorption of sex hormones like progesterone and testosterone.(3) Rat intestinal absorption of vinblastine, a well-known substrate of P-glycoprotein, is rapid in rat duodenum and ileum than expected. However, vinblastine absorption from jejunum is almost negligible, suggesting that P-glycoprotein restrict vinblastine absorption in regional-dependent manner. Such observation cannot be obtained in the study using Caco-2 cells.(4) When corrected for the secretory transport, permeation parameters of β-lactam antibiotics across rat jejunum are well correlated with their oral bioavailability in human. As a new understanding on the mechanism by which bacampicillin increase ampicillin absorption, it is indicated that a hydrolysis product, which is formed in the epithelium, inhibits the efflux system for β-lactam antibiotics.(5) [ィイD13ィエD1H] Vinblastine, absorbed from duodenum and ileum, is secreted into jejunal lumen much greater when unlabeled vinblastine is loaded in jejunal loop than when drug-free buffer was introduced. Unlabeled vinblastine also enhances the basolateral-to-apical transport of [ィイD13ィエD1H] vinblastine mediated by P-glycoprotein across Caco-2 cell monolayers. However, other P-glycoprotein substrates like doxorubicin, vincristine, and methylpredni-solone fail to exhibit such effect. A likely explanation is that the presence of the same substrate at the apical surface of epithelial cells is a key to stimulate P-glycoprotein-mediated transport. Less
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
和田育男: "HPLCによるエトポシドの体液中濃度測定法の改良と癌患者における薬物体内動態"TDM研究. 15. 251-258 (1998)
Ikuo Wada:“用于测量癌症患者体液中依托泊苷浓度和药物药代动力学的 HPLC 方法的改进”TDM Research 15. 251-258 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ikuo Wada, Michiko Satoh, Takeo Takeda, Takehito Nakabayashi, Takanori Honnma, Hiroshi Saitoh, Masahiko Takada, and Kazuyuki Hirano: "A rapid assay of granisetron in biological fluids from cancer patients."Biol. Pharm. Bull.. 21(5). 535-537 (1998)
Ikuo Wada、Michiko Satoh、Takeo Takeda、Takehito Nakabayashi、Takanori Honnma、Hiroshi Saitoh、Masahiko Takada 和 Kazuyuki Hirano:“癌症患者生物体液中格拉司琼的快速检测。”Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akira Nakayama, One Eguchi, Masataka Hatakeyama, Hiroshi Saitoh, and Masahiko Takada: "Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in rat intestine."Biol. Pharm. Bull.. 22(5). 535-538 (1999)
Akira Nakayama、One Eguchi、Masataka Hatakeyama、Hiroshi Saitoh 和 Masahiko Takada:“由于可能与大鼠肠道中的 P-糖蛋白相互作用,类固醇激素的吸收行为不同。”Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroshi Saitoh and Bruce J. Aungst: "Improvement of the intestinal absorption of a peptidomimetic, boronic acid thrombin inhibitor possibly utilizing the oligopeptide transporter."Pharm.Res.. 16(1). 1786-1789 (1999)
Hiroshi Saitoh 和 Bruce J. Aungst:“可能利用寡肽转运蛋白改善拟肽、硼酸凝血酶抑制剂的肠道吸收。”Pharm.Res. 16(1)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroshi Saitoh: "Improvement of the inte3stinal absorption of a peptidomimetic, boronic acid thrombin inhibitor possibly utilizing the oligopeptide transporter."Pharm. Res.. 16. 1786-1789 (1999)
Hiroshi Saitoh:“可能利用寡肽转运蛋白改善拟肽、硼酸凝血酶抑制剂的肠道吸收。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
Effect of menstrual cycle on the pharmacokinetics of P-glycoprotein substrates
-
批准号:15590136
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:2003
-
负责人:SAITOH Hiroshi
-
依托单位:
The Effect of heavy Application of Nitrogen on Flavonoid Metabolism in Apple Skin
-
批准号:07660074
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:SAITOH Hiroshi
-
依托单位: